NASDAQ:APLS - Apellis Pharmaceuticals, Inc.
$29.16
 $1.97
+7.25%
4:00PM EDT
2019-07-22
Apellis Pharmaceuticals, Inc., incorporated on September 25, 2009, is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit complement component 3 (C3), the central protein in the complement cascade. The Companys lead product candidate is APL-2.The Company is developing APL-1 for the treatment of chronic obstructive pulmonary disease (COPD) by inhaled administration. The Companys Advance APL-2 (intravitreal administration) into Phase II clinical development in GA and Phase II clinical development in wet AMD. The Company is developing APL-2 as monotherapy for GA, administered by intravitreal injections. In its ongoing Phase II clinical trial of APL-2 in patients with GA, treatment with APL-2 resulted in a reduction in the rate of GA lesion growth at 12 months compared to sham. The Company plan to discuss Phase III program in GA with the FDA and to initiate Phase III clinical trials of APL-2 in GA. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  APLS     avg for
industry  
  avg for
sector  
42 stocks weight:  100. 53   217. 37   399. 45  
42 stocks rank:  1. 74 K 1. 27 K 716. 99  
# analyst opinions:  7. 00   13. 21   13. 71  
mean recommendation:  1. 50   2. 10   2. 04  

quick ratio:  14. 22   5. 49   1. 88  
current ratio:  15. 23   5. 87   2. 36  

target price low:  37. 00   83. 44   114. 90  
target price avg:  45. 00   106. 20   137. 90  
target price high:  52. 00   132. 30   158. 97  
1-yr high:  27. 39   111. 86   142. 57  
last close:  27. 19   86. 79   125. 44  
50-day avg:  22. 57   86. 68   122. 63  
200-day avg:  17. 80   89. 22   121. 38  
1-yr low:  11. 47   69. 78   100. 51  
volume:  357. 73 K 2. 62 M 3. 43 M
50-day avg volume:  410. 53 K 3. 20 M 4. 16 M
200-day avg volume:  396. 27 K 2. 99 M 4. 75 M

1-day return:  -0. 73 % -1. 30 % -0. 99 %
this week return:  -0. 59 % 0. 45 % -0. 20 %
12-wk return:  34. 67 % 0. 94 % 4. 84 %
52-wk return:  49. 18 % -1. 30 % 10. 55 %

enterprise value (EV):  1. 44 B 45. 10 B 122. 38 B
market cap:  1. 72 B 38. 96 B 108. 40 B
total debt:  13. 37 M 10. 90 B 17. 48 B
debt/equity:  5. 95   57. 18   120. 05  
net income (common):  -156. 34 M 2. 07 B 4. 05 B

shares outstanding:  55. 94 M 538. 09 M 1. 24 B
shares:  39. 90 M 548. 00 M 1. 22 B
shares short:  2. 44 M 10. 98 M 11. 87 M
shares short prior month:  2. 27 M 9. 32 M 12. 05 M
short ratio:  5. 20   5. 60   3. 34  
short % of float:  5. 10 % 6. 48 % 2. 64 %
total cash/share:  4. 56   10. 98   9. 19  
total cash:  288. 25 M 5. 93 B 6. 10 B
free cash flow:  -88. 18 M 2. 92 B 4. 55 B
operating cash flow:  -143. 87 M 3. 80 B 5. 78 B

book value:  3. 56   13. 35   27. 45  
price/book:  7. 65   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -2. 78   2. 10   4. 23  
forward EPS:  -3. 43   3. 45   7. 10  
P/E:  -9. 79   1. 90   32. 10  
forward P/E:  -7. 93   6. 46   15. 47  
PE/G:  1. 62   0. 70   -0. 54  
growth:  -6. 06 % 265. 63 % 79. 11 %
earnings high:  -0. 68   0. 89   1. 68  
earnings avg:  -0. 77   0. 70   1. 57  
earnings low:  -0. 83   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -40. 27 % -2. 34 % 5. 28 %
return on equity:  -88. 38 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  2. 04   1. 27   0. 91  
sharpe (1yr):  0. 92   0. 16   0. 77  

held % insiders:  32. 55 % 6. 06 % 3. 29 %
held % institutions:  53. 65 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : APLS
.    137.155 =       137.155 :: --> INITIAL WEIGHT <--
.    - 2.778 =       134.377 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.256 =       303.179 :: P/E factor
.    x 0.959 =        290.72 :: PE/G factor
.    x 1.583 =       460.287 :: beta factor
.    x 0.972 =       447.301 :: sharpe factor
.    x 2.596 =      1161.096 :: current ratio factor
.    x 1.037 =      1204.194 :: quick ratio factor
.    x 1.092 =      1314.893 :: short ratio factor
.    x 1.089 =      1431.285 :: price-to-book factor
.    x 1.051 =      1503.883 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      3189.426 :: sector+industry 1-year gains factor
.    x 1.009 =      3219.496 :: industry 12-weeks return factor
.    x 1.308 =      4210.742 :: industry 2-weeks return factor
.    x 1.487 =      6263.132 :: company one-year gains+dividend factor
.    x 3.649 =     22852.352 :: company 13 weeks' performance factor
.    x 2.024 =     46251.849 :: 5-day avg > 200-day avg
.    x 1.808 =     83606.134 :: 5-day avg > 50-day avg
.    x 1.268 =    106022.718 :: 50-day avg > 200-day avg
.    x 0.977 =    103558.711 :: "drift" penalty 1 days ago
.    / 1.999 =     51802.546 :: overall "drift" factor
.    x 0.898 =     46511.067 :: largest single-day jump factor
.        x 1 =     46511.067 :: volatility factor
.        x 1 =     46511.067 :: 42-day volatility factor
.    x 1.634 =     75985.172 :: notable returns + performance factor
.    x 4.063 =    308749.847 :: performance vs s&p500 factor
.    x 3.626 =   1119654.706 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.675 =    756301.043 :: forward EPS factor
.    x 0.882 =     667114.07 :: forward P/E factor
.    x 1.185 =    790338.377 :: industry recommendation factor
.    x 2.927 =   2312926.465 :: company recommendation factor
.    x 1.003 =   2319322.595 :: factor historical industry gain for week 29
.    x 1.745 =   4047801.307 :: target low factor
.     x 1.27 =   5139807.968 :: target mean factor
.     x 1.04 =   5346015.708 :: target high factor
.   x 10.809 =  57785250.182 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        87.188 :: reduced for readability
.   + 13.338 =       100.526 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                    100.526 :: FINAL WEIGHT for NASDAQ:APLS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org